DecisionView Launches StudyOptimizer 4
San Francisco, CA – December 10, 2009
DecisionView Inc., a provider of software solutions to optimize clinical trial enrollment for life sciences companies, today announced the release of StudyOptimizer™ 4, the latest iteration of its Web-based solution. DecisionView’s flagship product now includes advanced historical analysis and templates capabilities, as well as enhancements to its predictive analytics technology.
StudyOptimizer allows clinical trial managers to plan, track, diagnose, and correct enrollment plans via a single centralized Web-based application that
captures clinical trial patient enrollment data from across the organization. The application uses predictive analytics to forecast enrollment trends and estimate completion dates, which are updated based on actual enrollment patterns giving clinical trial managers information to measure actual and projected performance against plan.
“The ability to capture, analyze, and leverage historical clinical trial enrollment data in planning future patient recruitment efforts provides a critical baseline that life sciences organizations need in order to benchmark and improve these processes,” said said Alan Louie, Ph.D., Research Director, IDC.
Recently, DecisionView announced the availability of the Software-as-a-Service (SaaS) version of StudyOptimizer.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
